Cancer cell resistance mechanisms: a mini review
Cancer is a leading cause of death worldwide accounting to 13 % of all deaths. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. This review sheds a light on some of the mec...
Gespeichert in:
| Veröffentlicht in: | Clinical & translational oncology 2014-06, Vol.16 (6), p.511-516 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 516 |
|---|---|
| container_issue | 6 |
| container_start_page | 511 |
| container_title | Clinical & translational oncology |
| container_volume | 16 |
| creator | Al-Dimassi, S. Abou-Antoun, T. El-Sibai, M. |
| description | Cancer is a leading cause of death worldwide accounting to 13 % of all deaths. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. This review sheds a light on some of the mechanisms developed by cancer cells to resist therapy as well as some of the structures involved such as the ABC members’ involvement in chemotherapy resistance and MET and survivin overexpression leading to radiotherapy resistance. Understanding those mechanisms will enable scientists to overcome resistance and possibly improve treatment and disease prognosis. |
| doi_str_mv | 10.1007/s12094-014-1162-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1526131308</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1526131308</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-5372b554ab653f5283052bb9d9655b5c0dd72a26997cc91019f51935b6f7e8223</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMorq7-AC_So5doJl9tvMniFyx4UfAWkjTVLNt2TbaK_96Urh49zTDzzss7D0JnQC6BkPIqASWKYwIcA0iKYQ8dgVQKMyLE_q4nvHqdoeOUViRPJcAhmlEueVlxeoTIwnTOx8L59bqIPoW0HQdF69276UJq03VhijZ0IW8_g_86QQeNWSd_uqtz9HJ3-7x4wMun-8fFzRI7xvkWC1ZSKwQ3VgrWCFrlSNRaVSsphBWO1HVJDc0BS-cUEFCNAMWElU3pK0rZHF1MvpvYfww-bXUb0pjSdL4fkgZBJTBgpMpSmKQu9ilF3-hNDK2J3xqIHkHpCZTOoPQISkO-Od_ZD7b19d_FL5ksoJMg5VX35qNe9UPs8sv_uP4Aon9wnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1526131308</pqid></control><display><type>article</type><title>Cancer cell resistance mechanisms: a mini review</title><source>MEDLINE</source><source>Springer Journals</source><creator>Al-Dimassi, S. ; Abou-Antoun, T. ; El-Sibai, M.</creator><creatorcontrib>Al-Dimassi, S. ; Abou-Antoun, T. ; El-Sibai, M.</creatorcontrib><description>Cancer is a leading cause of death worldwide accounting to 13 % of all deaths. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. This review sheds a light on some of the mechanisms developed by cancer cells to resist therapy as well as some of the structures involved such as the ABC members’ involvement in chemotherapy resistance and MET and survivin overexpression leading to radiotherapy resistance. Understanding those mechanisms will enable scientists to overcome resistance and possibly improve treatment and disease prognosis.</description><identifier>ISSN: 1699-048X</identifier><identifier>EISSN: 1699-3055</identifier><identifier>DOI: 10.1007/s12094-014-1162-1</identifier><identifier>PMID: 24647842</identifier><language>eng</language><publisher>Milan: Springer Milan</publisher><subject>Animals ; Drug Resistance, Neoplasm ; Educational Series - Blue Series ; Humans ; Medicine ; Medicine & Public Health ; Neoplasms - drug therapy ; Neoplasms - radiotherapy ; Oncology ; Radiation Tolerance</subject><ispartof>Clinical & translational oncology, 2014-06, Vol.16 (6), p.511-516</ispartof><rights>Federación de Sociedades Españolas de Oncología (FESEO) 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-5372b554ab653f5283052bb9d9655b5c0dd72a26997cc91019f51935b6f7e8223</citedby><cites>FETCH-LOGICAL-c344t-5372b554ab653f5283052bb9d9655b5c0dd72a26997cc91019f51935b6f7e8223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12094-014-1162-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12094-014-1162-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24647842$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Dimassi, S.</creatorcontrib><creatorcontrib>Abou-Antoun, T.</creatorcontrib><creatorcontrib>El-Sibai, M.</creatorcontrib><title>Cancer cell resistance mechanisms: a mini review</title><title>Clinical & translational oncology</title><addtitle>Clin Transl Oncol</addtitle><addtitle>Clin Transl Oncol</addtitle><description>Cancer is a leading cause of death worldwide accounting to 13 % of all deaths. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. This review sheds a light on some of the mechanisms developed by cancer cells to resist therapy as well as some of the structures involved such as the ABC members’ involvement in chemotherapy resistance and MET and survivin overexpression leading to radiotherapy resistance. Understanding those mechanisms will enable scientists to overcome resistance and possibly improve treatment and disease prognosis.</description><subject>Animals</subject><subject>Drug Resistance, Neoplasm</subject><subject>Educational Series - Blue Series</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasms - drug therapy</subject><subject>Neoplasms - radiotherapy</subject><subject>Oncology</subject><subject>Radiation Tolerance</subject><issn>1699-048X</issn><issn>1699-3055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMorq7-AC_So5doJl9tvMniFyx4UfAWkjTVLNt2TbaK_96Urh49zTDzzss7D0JnQC6BkPIqASWKYwIcA0iKYQ8dgVQKMyLE_q4nvHqdoeOUViRPJcAhmlEueVlxeoTIwnTOx8L59bqIPoW0HQdF69276UJq03VhijZ0IW8_g_86QQeNWSd_uqtz9HJ3-7x4wMun-8fFzRI7xvkWC1ZSKwQ3VgrWCFrlSNRaVSsphBWO1HVJDc0BS-cUEFCNAMWElU3pK0rZHF1MvpvYfww-bXUb0pjSdL4fkgZBJTBgpMpSmKQu9ilF3-hNDK2J3xqIHkHpCZTOoPQISkO-Od_ZD7b19d_FL5ksoJMg5VX35qNe9UPs8sv_uP4Aon9wnw</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>Al-Dimassi, S.</creator><creator>Abou-Antoun, T.</creator><creator>El-Sibai, M.</creator><general>Springer Milan</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Cancer cell resistance mechanisms: a mini review</title><author>Al-Dimassi, S. ; Abou-Antoun, T. ; El-Sibai, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-5372b554ab653f5283052bb9d9655b5c0dd72a26997cc91019f51935b6f7e8223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Drug Resistance, Neoplasm</topic><topic>Educational Series - Blue Series</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasms - drug therapy</topic><topic>Neoplasms - radiotherapy</topic><topic>Oncology</topic><topic>Radiation Tolerance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Dimassi, S.</creatorcontrib><creatorcontrib>Abou-Antoun, T.</creatorcontrib><creatorcontrib>El-Sibai, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical & translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Dimassi, S.</au><au>Abou-Antoun, T.</au><au>El-Sibai, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer cell resistance mechanisms: a mini review</atitle><jtitle>Clinical & translational oncology</jtitle><stitle>Clin Transl Oncol</stitle><addtitle>Clin Transl Oncol</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>16</volume><issue>6</issue><spage>511</spage><epage>516</epage><pages>511-516</pages><issn>1699-048X</issn><eissn>1699-3055</eissn><abstract>Cancer is a leading cause of death worldwide accounting to 13 % of all deaths. One of the main causes behind the failure of treatment is the development of various therapy resistance mechanisms by the cancer cells leading to the recurrence of the disease. This review sheds a light on some of the mechanisms developed by cancer cells to resist therapy as well as some of the structures involved such as the ABC members’ involvement in chemotherapy resistance and MET and survivin overexpression leading to radiotherapy resistance. Understanding those mechanisms will enable scientists to overcome resistance and possibly improve treatment and disease prognosis.</abstract><cop>Milan</cop><pub>Springer Milan</pub><pmid>24647842</pmid><doi>10.1007/s12094-014-1162-1</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1699-048X |
| ispartof | Clinical & translational oncology, 2014-06, Vol.16 (6), p.511-516 |
| issn | 1699-048X 1699-3055 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1526131308 |
| source | MEDLINE; Springer Journals |
| subjects | Animals Drug Resistance, Neoplasm Educational Series - Blue Series Humans Medicine Medicine & Public Health Neoplasms - drug therapy Neoplasms - radiotherapy Oncology Radiation Tolerance |
| title | Cancer cell resistance mechanisms: a mini review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A27%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20cell%20resistance%20mechanisms:%20a%20mini%20review&rft.jtitle=Clinical%20&%20translational%20oncology&rft.au=Al-Dimassi,%20S.&rft.date=2014-06-01&rft.volume=16&rft.issue=6&rft.spage=511&rft.epage=516&rft.pages=511-516&rft.issn=1699-048X&rft.eissn=1699-3055&rft_id=info:doi/10.1007/s12094-014-1162-1&rft_dat=%3Cproquest_cross%3E1526131308%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1526131308&rft_id=info:pmid/24647842&rfr_iscdi=true |